MEDICUS PHARMA LTD. Interest Expense
MEDICUS PHARMA LTD. (MDCX) reported Interest Expense of $205.64 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement
us-gaap:InterestExpense · last filed 2026-08-12
- MEDICUS PHARMA LTD. interest expense for the quarter ending 2026-06-30 was $205.64K.
- MEDICUS PHARMA LTD. interest expense for the quarter ending 2026-03-31 was $374.71K.
- MEDICUS PHARMA LTD. interest expense for the quarter ending 2025-06-30 was $0.00.
- MEDICUS PHARMA LTD. interest expense for the quarter ending 2025-03-31 was $0.00.
| Period end | Interest Expense 3 month | Interest Expense 6 month |
|---|---|---|
| 2026-06-30 | $205.64K 10-Q · filed 2026-08-12 | $523.79K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $374.71K 10-Q · filed 2026-05-14 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |